Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Earnings
Pharma
J&J lifts 2025 sales guidance despite looming tariff threat
Even as tariffs start to impact its medtech business, Johnson & Johnson is lifting its sales guidance for 2025 thanks to a recent neuroscience buyout.
Fraiser Kansteiner
Apr 15, 2025 11:55am
WuXi Bio, WuXi XDC upbeat on 2025 after strong 2024 earnings
Mar 25, 2025 10:45am
WuXi AppTec offers rosy 2025 guidance despite US-China tensions
Mar 18, 2025 4:30pm
Breaking down pharma’s Q4 sales boom
Mar 14, 2025 9:00am
Akebia sketches out pivotal Vafseo study in nondialysis patients
Mar 13, 2025 3:28pm
J&J, Legend to invest $150M in Belgium cell therapy facility
Mar 12, 2025 2:15pm
